Zydus receives final approval from USFDA for Scopolamine Transdermal System 1 mg/3 days
BILKULONLINE Ahmedabad, Aug 30: Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval
Read more